Carmen Herrero

Dr. Carmen Herrero is an accomplished professional with a strong educational background and extensive experience in the field of biochemistry, immunology, and business management.

She holds a PhD in Biochemistry & Immunology from Universitat de Barcelona, showcasing her expertise in the scientific domain.

Additionally, Carmen pursued studies in Competitive Intelligence and Technological Surveillance at Universitat Pompeu Fabra, demonstrating her interest in staying updated with the latest trends and innovations.

Moreover, she furthered her knowledge by completing an Executive MBA in Management from EAE Business School, highlighting her strategic and leadership skills.

Throughout her career, Carmen has held key positions in various renowned organizations, including being the Co-founder and CEO of Kintsugi Therapeutics, where she drives the vision and growth of the company.

Prior to Kintsugi Therapeutics, she served as the Vice President of Research and Development, as well as the Chief Scientific Officer at Spiral Therapeutics, showcasing her strong leadership and research abilities.

Carmen also held pivotal roles at Loop Therapeutics, Inc., Laboratorios SALVAT, and HIPRA, where she contributed significantly to the advancement of biochemistry, cell biology, and immunology.

Her diverse experience ranges from managing R&D projects to leading scientific teams, reflecting her versatility and expertise in the pharmaceutical and biotech sectors.

With a solid academic foundation, combined with her hands-on industry experience, Carmen Herrero emerges as a dynamic professional with a passion for innovation and scientific advancement.